Buying a train ticket with a bicycle will become easier; getting the bike onto the train won't
Keystone / Gaetan Bally
Ticket prices for Swiss public transport will remain stable for 2023 for the seventh consecutive year. Only “a few tourist businesses” are planning to adjust their fares for next year, says the SwissPass Alliance.
This content was published on
1 minute
Keystone-SDA/ts
Português
pt
A boa notícia: tarifas de transporte público não subirão em 2023
In addition, from December 11, when the new Swiss Federal Railways timetable comes into effect, there will be a customer group specific to bicycles and dogs, which will allow “simplified” ticket purchasing.
SwissPass explained it would be possible to select whether you are travelling with a bike or a dog during the purchase process, and the sales system would issue the ticket at the best price.
Only the connections that allow you to load your bike will be indicated. There will also be more of these connections.
The Dog PassExternal link introduced last December will also be available as a monthly subscription.
SwissPass said the RailPlusExternal link discount card, which gave a 15% discount on tickets to many European countries, would be discontinued. The card has continually lost its appeal because of Supersaver Tickets, with which it was not compatible.
More
More
How to behave on a Swiss train
This content was published on
Jump on, ride to your stop, hop off — without offending anybody. Sounds easy, but it’s not, warns a guru of Swiss transport etiquette.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.